logo-loader
ASX:ACW

Actinogen Medical Ltd

Receive alerts
Market:
ASX
Market Cap:
$7.83 m
Price
$0.01
Change
-6.67%
52 weeks high
0.06
52 weeks low
0.01

Filter by article type

Viewing results 1-25 of 27

Health

Actinogen Medical opens SPP after successful $15 million placement

Funding will go towards the company's lead drug candidate Xanamem™....

on 6/6/18
Health

Actinogen Medical attracts $15 million to progress Alzheimer’s disease therapy

The company's shares are trading about 9% higher intra-day, at 4.9 cents....

on 23/5/18
Health

Actinogen Medical enrols first UK patient in Alzheimer’s therapy trial

The annual cost of managing Alzheimer’s disease is estimated to be US$250B in the U.S....

on 16/8/17
Health

Actinogen Medical begins landmark Alzheimer’s disease clinical trial

The largest Alzheimer’s study ever conducted by an Australian company....

on 16/5/17
Health

Actinogen Medical on track to begin Alzheimer’s disease trial

The company has received approval for the trial in the UK....

on 10/2/17
Health

Actinogen Medical in an ASX trading halt

Actinogen Medical (ASX:ACW) has been granted a trading halt by the ASX, with its shares placed in pre-open....

on 30/12/16